Diabetes Management Journal intends to publish peer-reviewed, original articles that address the global health concerns related to diabetes. It provides clinicians with the latest findings and opinions on the optimum therapies to check the ever expanding diabetes. It is an open access, online, international journal with a primary objective to reach the readers and researchers globally.
Diabetes Management presents findings, analysis and commentary on the battle with Type I and Type II diabetes. Articles published in Diabetes Management address improvements in current therapeutics and patient compliance together with perspectives on future prospects. Coverage focuses on the key objective of stabilizing blood glucose levels in individuals with either form of the disease, and the associated issues of patient co operation and education. The journal also reflects the frontiers of current research, such as attempts to recreate pancreatic cells through stem cell technology or islet cell transplantation, the development of a vaccine for Type 1 disease and the potential for biomarkers to be used for the detection. The increasing understanding of the molecular basis of the disease and associated genetics will play an important part in future diabetes management.
The journal encourages broader research perspectives including Clinical Care, Education and Nutrition to fight diabetes. The journal also focuses on aspects involving Psychosocial Research, Epidemiology, Health Services Research on Emerging Treatments and Technologies to deal with Pathophysiology, Complications, Cardiovascular and Metabolic Risk.
INDEXING: EMBASE, Excerpta Medica, CAS (Chemical Abstracts Service), EMCare, CNKI (China National Knowledge Infrastructure)
Submit your manuscripts through Editorial Manager®: www.editorialmanager.com/openaccessjournals
Contact Editorial Office at [email protected] / [email protected]
Research Article p. 41-45
Author(s): Shatokhina I.V
High risk of vascular complications in diabetes foundation gave the American Heart Association ranked diabetes to diseases of the cardiovascular system. More than 60% of patients with type 2..
Short Communication p. 46-50
Author(s): Diana L. Malkin-Washeim
Opinion Article p. 51-52
Author(s): Julie DeFruscio